ED
ZLAB icon

Exane Derivatives’s Zai Lab ZLAB Stock Holding History

Exane Derivatives’s Portfolio ZLAB Stock Details ZLAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-1,091
Closed -$115K – 1087
2021
Q3 		$115K Buy
1,091
+306
+39% +$43.9K 0.03% 503
2021
Q2 		$134K Buy
785
+456
+139% +$73.4K 0.03% 508
2021
Q1 		$43.9K Buy
+329
New +$50.9K 0.01% 528

Other funds holding ZLAB

Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BAM
Brilliance Asset Management Admiralty, Hong Kong, Hong Kong $339M AUM 9.81% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Exane Derivatives's ZLAB Position: Q4 2021 in Review

Exane Derivatives sold out of Zai Lab (ZLAB) in Q4 2021, closing a stake of 1,091 shares — an estimated $115K sold.

Exane Derivatives first reported a position in ZLAB in Q1 2021 and held it in 3 quarters. The position peaked at $134K in Q2 2021. 206 funds tracked by Wall St. Rank hold ZLAB as of Q4 2021.

  • Exane Derivatives reported no remaining Zai Lab position as of Q4 2021 after selling out during the quarter.
  • Exane Derivatives sold 1,091 Zai Lab shares in Q4 2021, an estimated $115K.
  • Exane Derivatives first reported a position in Zai Lab in Q1 2021 and held it in 3 quarters.
  • Exane Derivatives's Zai Lab position peaked at $134K in Q2 2021.
  • 206 funds tracked by Wall St. Rank held Zai Lab as of Q4 2021.

Based on Exane Derivatives's 13F filing for Q4 2021, filed 28 Jan 2022.